High-technology clusters in France: Two unusual models - an empirical study

Health Policy and High-Tech Industrial Development: Learning from Innovation in the Health Industry

Volumn , Issue , 2005, Pages 258-278

  Katz Bénichou, Grégory ^a   Viens, Gérard ^a  

^a ESSEC BUSINESS SCHOOL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881755893     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4337/9781845424565.00024     Document Type: Chapter

References (22)

1. Bakouros, Y., Mardas, D. and Varsakelis, N., ‘Science park, a high tech fantasy: an analysis of the science parks of Greece’, Technovation, 22(2), February 2002, 123-8.
2. Barre, R. and Esterle, L. (eds), ‘Indicateurs 2002, Rapport de l’Observatoire des Sciences et des Techniques’, Economica, 2002.
3. Blumberg-Morki, M., ‘Biotechnologies: une strategie pour l’ Europe, Biofutur, 222, May 2002.
4. Brouthers, K. and Werner, S., ‘R&D mode choices in Central and Eastern Europe’, Journal of Business Research, 52(1), April 2001, 83-91.
5. Busquin, P., ‘Le fossé Europe Etat-Unis se creuse’, La Recherche, June 2002.
6. Busquin, P., Jacob, F., Montagnier, L. et al., Quel avenir pour la recherche?, Paris: Flammarion, 2003.
7. Cueni, Thomas, ‘The research-based pharmaceutical industries in Europe’, Pharmaceuticals Policy and Law, 1, 1999, 37-47.
8. Ernst & Young, ‘Life Sciences in France’, 2001.
9. Faure, P., Vidal, H., Pollard, H. et al., ‘Genopole d’Evry et l’expérience de 10 technopolis français’, Genopole Annual Report, March 1999.
10. Kanavos, P., ‘A prospective view on European pharmaceutical research and development’, Pharmacoeconomics, 13 (2), February 1998, 181-90.
11. Katz-Bénichou, G. and Faure, P., ‘Benchmarking of biotech economic developments: a comparative study of France, Germany and United Kingdom’, ESSEC Business School, Cergy, 2001.
12. Kihlgren, A., ‘Promotion of innovation activity in Russia through the creation of science parks: the case of St. Petersburg’, Technovation, 23(1), January 2003, 65-76.
13. Kopp, P. and Prud’homme R., ‘Dépénaliser l’innovation’, Objectif, 2010 and France Biotech, discussion paper, 26 March 2002.
14. Lenoir, N., ‘Relever le défi des Biotechnologies’, a report to the French Ministry of Economy and Finance and the Ministry of Research, 11 March 2002.
15. Löfsten, H. and Lindelöf, P., ‘Science parks in Sweden - industrial renewal and development?', R&D Management, 31(3), 2001, 309-22.
16. Löfsten, H. and Lindelöf, P., ‘Science parks and the growth of new technologybased firms, academic-industry links, innovation and markets’, Research Policy, 31(6), August 2002, 859-76.
17. Monck, C.S.P., Science Parks and the Growth of High Technology Firms, London: Croom Helm, 1988.
18. Mothe, C. and Quelin, B., ‘Creating competencies through collaboration: the case of Eureka R&D consortia’, European Management Journal, 18(6), December 2000, 590-604.
19. Pammolli, F., Riccaboni, M., Owen-Smith, J. and Powell, W., ‘Europe/Etats-Unis: la force de réseaux’, Biofutur, 222, May 2002, 26.
20. Shin Dong-Ho, ‘An alternative approach to developing science parks: a case study from Korea’, Regional Science, 80, August 2000, 103-11.
21. Storey, D.J. and Tether, B.S., ‘Public policy measures to support new technologybased firms in the European Union’, Research Policy, 26, 1998, 1037-57.
22. Westhead, P. and Storey, D.J., ‘Links beween higher education institutions and high technology firms’, International Journal of Management Science, 23(4), 1995, 345-60.